Reviews of Pediatric Studies Conducted under BPCA and Pediatric assessments conducted under PREA from 2012 – present

Summary

FDA published reviews of pediatric studies conducted under BPCA (Best Pharmaceuticals for Children Act) and PREA (Pediatric Research Equity Act) from 2012 to present. This is a routine regulatory disclosure document without information on specific drugs, companies, or trial outcomes.